Omeros (OMER) Non-Current Deferred Tax Liability (2020)

Omeros (OMER) reported Non-Current Deferred Tax Liability of $4.2 million for Q3 2020.

Omeros (OMER) Non-Current Deferred Tax Liability (2020) Analysis & Trends

Omeros (OMER) has 1 years of Non-Current Deferred Tax Liability data on file, last reported at $4.2 million in Q3 2020.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn
4	NuCana	279.75 Bn	279.75 Bn	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn
7	Belite Bio	62.51 Bn	62.51 Bn	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn
9	Revolution Medicines	37.78 Bn	37.78 Bn	-
10	Omeros	739.31 Mn	739.31 Mn	9.31 Mn

Download Data

Date	Value
Sep 30, 2020	4.16 Mn
Sep 30, 2020	4.16 Mn